Pinealon
Short Peptide Bioregulator - Short peptide bioregulator studied for neural protection.
Pinealon is a short peptide bioregulator studied for its reported ability to cross into neural tissue and support cellular protein synthesis in brain-research models.
Pinealon belongs to the short peptide-bioregulator class studied for tissue-specific effects on cellular protein synthesis, with particular attention to neural tissue. Its research literature is preclinical and mechanistic detail is still being characterised.
Pinealon specifications
- Sequence
- Glu-Asp-Arg (tripeptide)
- Presentation
- Lyophilised powder
- Documented purity
- 99.61% by HPLC
- Available sizes
- 10mg ($65)
- Archived COA lots
- 2
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Neural protein synthesis - Investigated for peptide-bioregulation activity in neuro-protection studies.
Reported mechanisms in the literature
- Neural protein synthesis - A short peptide bioregulator studied for its reported ability to reach neural tissue and support cellular protein synthesis in brain-research models. (Khavinson et al.)
Pinealon frequently asked questions
What is Pinealon?
A short peptide bioregulator (Glu-Asp-Arg) studied for peptide-bioregulation activity and neural protection in brain-research models.
Is Pinealon approved for human use?
No. It is a research material only, with preclinical data only.
What is it researched for?
Neural protein synthesis and neuroprotection in cell and animal models.
Documented to 99.61% purity by HPLC · third-party COA every lot · from $65 · For laboratory research use only.